The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients.

Abstract

1. The pharmacokinetics of and therapeutic response to recombinant human erythropoietin (rcEPO) were studied in 12 patients under chronic haemodialysis on a thrice weekly intravenous rcEPO treatment scheme. The kinetics of rcEPO were also assessed after a subcutaneous injection during the initial period and during maintenance treatment. RcEPO was measured… (More)

Topics

Cite this paper

@article{Brockmller1992ThePA, title={The pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in haemodialysis patients.}, author={J{\"{u}rgen Brockm{\"{o}ller and Joachim Koechling and Warren E. Weber and Michael Looby and Ivar Roots and H. H. Neumayer}, journal={British journal of clinical pharmacology}, year={1992}, volume={34 6}, pages={499-508} }